Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/19/2024 04:13 AM
Pennsylvania State Senate
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=S&SPick=20170&cosponId=26487
Share:
Home / Senate Co-Sponsorship Memoranda

Senate Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


Senate of Pennsylvania
Session of 2017 - 2018 Regular Session

MEMORANDUM

Posted: October 9, 2018 02:27 PM
From: Senator Patrick M. Browne and Sen. Lisa Baker, Sen. Judith L. Schwank
To: All Senate members
Subject: Expedited Partner Therapy
 
In the near future, Senator Baker, Senator Schwank and I will be introducing legislation that provides for the authority to prescribe or personally furnish antibiotics to treat sexually transmitted infections, without having examined the individual for whom the drug is intended, in accordance with the Expedited Partner Therapy (EPT) in the Management of Sexually Transmitted Diseases guidance document issued by the United States Center for Disease Control (CDC), under certain conditions.

Sexually transmitted infections are a serious public health concern. According to the CDC, the United States is experiencing steep, sustained increases in sexually transmitted infections. Rates of syphilis, gonorrhea and chlamydia have climbed for the fourth consecutive year. STIs caused by bacteria can be treated and often cured with antibiotics, yet most cases go untreated or undiagnosed. Reinfection or lack of treatment can cause serious health problems including pelvic inflammatory disease, chronic pelvic pain, infertility and potentially life-threatening ectopic pregnancies. STIs also place a significant economic strain on the healthcare system. The CDC conservatively estimates that the lifetime cost of treating eight of the most common sexually transmitted infections contracted in just one year is $15.6 billion. Because these infections are preventable, significant reductions in new infections are not only possible, they are urgently needed.

The CDC recommends EPT be available to clinicians as a useful option for partner treatment to reduce the risk of reinfection and prevent further spread of the infection. EPT is permissible in 42 states with more than 30 states enacting laws to expressly authorize EPT. This includes the surrounding states of Ohio, Maryland, Delaware, Virginia, West Virginia, New York and the District of Columbia.

Please join us in co-sponsoring this important legislation.



Introduced as SB1114